Datwani Hema, Moro Pedro L, Harrington Theresa, Broder Karen R
Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Zoonotic and Emerging Infectious Diseases (NCZEID), Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, United States.
Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Zoonotic and Emerging Infectious Diseases (NCZEID), Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, United States.
Vaccine. 2015 Jun 17;33(27):3110-3. doi: 10.1016/j.vaccine.2015.04.097. Epub 2015 May 11.
In October 2012, the Advisory Committee on Immunization Practices (ACIP) recommended a dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) during each pregnancy, irrespective of the woman's prior history of receiving Tdap. A retrospective cohort study to assess the safety of Tdap vaccination in pregnant women in two Vaccine Safety Datalink (VSD) sites during 2010-2012 found a small but statistically significant increased risk of chorioamnionitis.
We conducted a review of the VAERS database to describe reports of chorioamnionitis following receipt of any vaccines.
We searched the VAERS database for reports of chorioamnionitis after any vaccine in the United States during the period from July 1, 1990 through February 2, 2014.
VAERS received 31 reports of chorioamnionitis out of 3389 pregnancy reports in 24 years. The three most common vaccines in these reports were 2009 H1N1 inactivated influenza, quadrivalent human papillomavirus (HPV4), and Tdap vaccines in 32%, 29% and 26% of reports, respectively. Fifty-eight percent of reports had at least one reported risk factor for chorioamnionitis. Chorioamnionitis was identified in 3 reports of spontaneous abortions and 6 stillbirths, 6 reports of preterm birth (two of whom died) and 16 reports of term birth; maternal outcomes included two reports of postpartum hemorrhage and one report of maternal admission to the intensive care unit. No maternal deaths were reported.
Chorioamnionitis was found to be uncommonly reported, representing 1% of pregnancy reports to VAERS. A majority of reports had at least one risk factor for chorioamnionitis.
2012年10月,免疫实践咨询委员会(ACIP)建议在每次妊娠期间接种一剂破伤风类毒素、白喉类毒素减少量和无细胞百日咳疫苗(Tdap),无论该女性既往是否接种过Tdap。一项回顾性队列研究评估了2010 - 2012年期间两个疫苗安全数据链(VSD)站点孕妇接种Tdap疫苗的安全性,发现绒毛膜羊膜炎风险虽小但具有统计学意义的增加。
我们对疫苗不良事件报告系统(VAERS)数据库进行了回顾,以描述接种任何疫苗后绒毛膜羊膜炎的报告情况。
我们在VAERS数据库中搜索了1990年7月1日至2014年2月2日期间美国接种任何疫苗后发生绒毛膜羊膜炎的报告。
在24年的3389份妊娠报告中,VAERS收到了31份绒毛膜羊膜炎报告。这些报告中最常见的三种疫苗分别是2009年甲型H1N1流感灭活疫苗、四价人乳头瘤病毒(HPV4)疫苗和Tdap疫苗,分别占报告的32%、29%和26%。58%的报告至少有一项绒毛膜羊膜炎的报告风险因素。在3例自然流产报告、6例死产报告、6例早产报告(其中2例死亡)和16例足月产报告中发现了绒毛膜羊膜炎;产妇结局包括2例产后出血报告和1例产妇入住重症监护病房的报告。未报告产妇死亡。
发现绒毛膜羊膜炎的报告不常见,占向VAERS报告的妊娠报告的1%。大多数报告至少有一项绒毛膜羊膜炎的风险因素。